Valsartan is a decades-old treatment for hypertension that is frequently combined with other medicines into a single pill. Blood Pressure Medication Recalled FDA says active ingredient is linked to a known probable carcinogen. An online pharmacy told U.S. regulators it found another cancer-causing chemical in widely prescribed blood-pressure pills, raising new questions about a complex global web of companies that produces medicine for millions of people. A recent letter one consumer received from his pharmacy alerting him to check to see if his medication containing valsartan was among the lots listed in the letter under recall for “purity issues.”. For a complete list of the recalled medication, click here. The recalls were over the presence of NMBA. An FDA statement Friday disclosed that the contaminants, called N-Nitrosodimethylamine and N-Nitrosodiethylamine, are created when "specific chemicals and reaction conditions are present . One consumer receiving a recent letter from his pharmacy on a recall of valsartan medication noted that he received a similar letter last year over “purity” issues. Legacy Pharmaceutical Packaging issued two company announcements March 15, saying in one that it was recalling 40 repackaged lots of losartan tablets in 25-milligram, 50-mg, and 100-mg dose due to distributor Camber Pharmaceuticals Feb. 28 voluntary recall, and in another that it had recalled three repackaged lots of losartan tablets in 50-mg dose due to Torrent Pharmaceuticals voluntary nationwide March 1 recall of several lots of losartan tablets. A Bloomberg News investigation this year detailed efforts at the company to manipulate data and ignore warning signs that their drugs didn't meet U.S. standards. Registration on or use of this site constitutes acceptance of our User Agreement, Privacy Policy and Cookie Statement, and Your California Privacy Rights (each updated 1/1/21). Facebook Share. A Food and Drug Administration recall of a heart medication due to a cancer-causing chemical now includes two blood pressure medications. Fda.gov said the recall was due to t to the detection of trace amount of an unexpected impurity. The U.S. Food and Drug Administration has updated its lists of valsartan and losartan-containing blood pressure medicines under recall due to the detection of an impurity considered carcinogenic above certain levels in the active pharmaceutical ingredient. FDA is alerting the public about a voluntary recall of several drug products containing valsartan, used to treat high blood pressure and heart failure April 19, 2019 / 1:31 PM / CBS News . For now, if you are taking blood pressure medications, or any medications for that matter, pay attention to FDA warnings and recall news. This recall was prompted due to Camber Pharmaceuticals, Inc. issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, (API manufacturer). American Health Packaging added to the list of recalls on March 7, 2019. The FDA allows drugs to contain the equivalent of about 8.8 million nanograms of daily exposure to DMF. A recall of common blood pressure medication losartan has been expanded for a fifth time after manufacturer Torrent Pharmaceuticals found a possibly carcinogenic impurity in … Torrent Pharmaceuticals widened its recall to include 114 additional lots of losartan potassium and losartan potassium/hydrochlorothiazide combination tablets, the … Carton NDC#: 60687-139-01 As blood-pressure drug recall widens, doctors say patients should pay attention, but warned against dropping a medication without professional guidance. Only Generics. The company added five lots of the generic drug losartan (three lots of losartan potassium tablets and two lots of losartan potassium/hydrochlorothiazide tablets) to an April recall of more than 100 lots of the same medications. ** Most commonly prescribed blood pressure medications have an array of similar side effects. The FDA said in a March 22 posting on its website that it has updated the list of valsartan medicines under recall to incorporate additional repackagers of Aurobindo’s valsartan-containing medicine. / Blood Pressure Medication Recall List. Late last month, Teva Pharmaceuticals pulled all lots of Amlodipine/Valsartan and Amlodipine/Valsartan/Hydrochlorothiazide combination tablets for the same reason: too much NDEA in its Valsartan, the active ingredient made by Mylan India. According to fda.gov, as of Feb. 22, 2019: Macleods Pharmaceuticals Limited is voluntarily recalling one lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer level due to the detection of trace amounts of an unexpected impurity (NDEA) found in finished product manufactured with active pharmaceutical ingredient made by Hetero Labs Limited. The FDA, which has issued acceptable intake levels for these nitrosamines that may result from the manufacturing process, has been working with their manufacturers to update testing and to reduce and remove them. The peripheral adrenergic inhibitors work in the brain to block signals that tell blood vessels to constrict. New research presented today at … Lower in the list are the Teva Pharmaceuticals lots under voluntary recall, as posted at fda.gov. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Advance Local. Making Sense of the Recent Blood Pressure Drug Recalls. An FDA spokeswoman said the investigation continues and it is impossible to predict how many more recalls there might be. The recall covers two types of hypertension-treating tablets including Losartan potassium tablets and Losartan potassion / Hydrocholothiazide tablets. Those suppliers provide components including inactive ingredients, of which Diovan has about eight. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Advance Local. Company Medicine NDC Lot Number Expiration; A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Valsartan 80mg Tablet: 54569-6582-1 : 342B17019: 09/2019: A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Valsartan 80mg Tablet: 54569-6582-1 : 342B17018: 08/2019: A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) … For every 8,000 people who took the highest dose of valsartan contaminated with NDMA, there would be one additional case of cancer, the FDA has estimated. Is your blood pressure medication on growing recall list? STOCK PHOTO/Getty Images. He added that his letter referenced that "some bottles of valsartan were recalled because of purity issues" but did not mention them as carcinogenic. Teva Pharmaceuticals has issued a voluntary recall … American Health Packaging issued a voluntary recall March 7 of one lot of valsartan tablets in 160-mg dose prompted by manufacturer AurobindoPharma USA’s March 1 voluntary recall of additional lots of valsartan due to the detection of NDEA in the active pharmaceutical ingredient. The agency last revised its allowable solvent levels in 2017; the WHO classified DMF as a probable carcinogen in 2018. You may have questions, we have answers. . The agency said those byproducts would not have been detected in routine inspections because the process depends on scientists knowing which chemical intruders are likely to be accidentally created during the process, knowledge that they said regulators and companies lacked until recently. A week after two more blood pressure drugs were recalled because they have a possible cancer-causing ingredient, the U.S. based Mylan Pharmaceuticals expanded its consumer-level voluntary nationwide recall to include all lots of Valsartan-containing products within dates of expiration. Problems with potential cancer-causing agents in blood-pressure medications first cropped up in July, when an ARB called valsartan was recalled by Chinese drugmaker Zhejiang Huahai Pharmaceutical Co. A Bloomberg investigation found that an FDA inspector had raised concerns at the factory that made the valsartan in May 2017. Diovan's DMF levels were among the lowest that tested positive. Valsartan has been in shortage since August, and the agency warned in its statement that "other types of products may fall into shortage soon," without offering any specifics. Top Searches Holiday Gifts. See list above for the lots recalled in December. According to the Food and Drug Administration, NDEA is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes. Twitter Share. But the official limit considered "safe" for human consumption brings a much lower risk than the possible exposure from tainted drugs - causing less than one additional case of cancer in 100,000 people over a lifetime. The agency has downplayed the public health risks of the contamination, pointing out that if 8,000 people took the highest dose of one drug, valsartan, for four years, there could be one additional case of cancer. —The 104 additional lots include 26 lots of Amlodipine and Valsartan tablets, USP (including the 5mg/160mg, 10mg/160mg, 5mg/320mg and 10mg/320mg strengths). The three impurities are chemical compounds in the nitrosamines class and NDEA and NDMA are considered to be a probable cancer-causing risk in humans at certain exposure levels, and NDMA a potential one. But companies that its suppliers buy from could. Drugs used to treat High Blood Pressure The following list of medications are in some way related to, or used in the treatment of this condition. Registration on or use of this site constitutes acceptance of our User Agreement, Privacy Policy and Cookie Statement, and Your California Privacy Rights (each updated 1/1/21). The agency is urging patients to continue taking their medications until a pharmacist or doctor provides another option because they need to balance the risks of out-of-control blood pressure against that of a tiny elevated risk of cancer. Another 35 lots of heart and blood pressure medication losartan have been recalled because of unsafe amounts of NMBA in the active ingredient. The agency said that the risk of a patient who took a recalled ARB getting cancer is low. Hundreds of lots of the medication have been recalled since last July. Even more recalls for blood pressure medications. by Kent Allen, AARP, August 7, 2018 | Comments: 0. If you take valsartan for your high blood pressure, check the FDA lists. The FDA regulates those less stringently than the active ingredients that fight disease. … (CBS) Another pharmaceutical company is recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical. Subscribe to MassLive.com. The FDA announced March 12 that it had prioritized approval of another generic version of Diovan, that is, valsartan, in recognition of the multiple recalls of ARB medicines over the detection of nitrosamine impurities above interim acceptable intake limits. Another blood pressure medication has been recalled over concerns it could contain trace amounts of carcinogens. The FDA has added 80 lots of Amlodipine Valsartan blood pressure medication to the hypertension drug recall list that continues to grow. See also: sub-topics. For people with high blood pressure, fluctuating readings are a warning sign that you might need to change medication. More blood pressure drugs are being recalled after being found to contain trace amounts of a potentially cancer-causing ingredient, one of a slew of recalls of medications to treat hypertension. An Attorney who has filed 12 high blood pressure medication lawsuits so far, told judges at a conference in the U.S. District Court in New Jersey last month he expected there to be at least 2000 high blood pressure medication lawsuits filed within the next two years. This includes some combination tablets which contain valsartan and amlodipine or valsartan, amlodipine, and hydrochlorothiazide. Alembic doesn't use DMF in its manufacturing process, according to spokesman Ajay Desai, who said the contamination likely occurred during analysis. The FDA posted Mylan labels, also at fda.gov. Another blood pressure medication has been recalled over concerns it could contain trace amounts of carcinogens. See above for additional recalls by Torrent. A representative for Macleods couldn't be reached for comment. Keep reading to find information about the earlier Teva recall and voluntary recalls by many other companies that make blood pressure medications. Latest blood pressure medication recall list, updated September 2019. Blood pressure medication recall expanded again over potential cancer-causing ingredient. Here are the 10 lots. Facebook Share. Select drug class. "This is what made me look up the website given in the letter on the FDA recall," he said. Here's how to know what medications were impacted and who to contact. According to the FDA, Valsartan is used for the treatment of high blood pressure and for the treatment of heart failure, and to reduce cardiovascular mortality following myocardial infarction. and may also result from the reuse of materials, such as solvents." Valisure found DMF in valsartan made by five of the six drugmakers it tested, including Novartis, which makes the brand-name version called Diovan. You may have recently heard that FDA has recalled several blood pressure medications. If you take valsartan for your high blood pressure, check the FDA lists. Getty Images. The carcinogens are found in smoked and grilled meats. In addition, it has updated the list of valsartan medicines not under recall as of March 19. Valsartan in combination with Amlodipine or Hydrochlorothiazide is used for the treatment of high blood pressure. Kirk Hessels, a spokesman for Camber, didn't immediately respond to requests for comment on Friday. / Blood Pressure Medication Recall List. The impurity detected in the finished drug product is N-nitrosodiethylamine, which is has been classified as a probable human carcinogen. Following that is earlier Mylan recalls. The FDA has said it thinks the potential carcinogens, known as nitrosamine impurities, are a result of the manufacturing processes the companies used. Teva Pharmaceuticals has issued a voluntary recall of its amlodipine/valsartan combination tablets and amlodipine/valsartan/hydrochlorothiazide combination tablets, both used to treat high blood pressure, according to the FDA. by Kent Allen, AARP, August 7, 2018 | Comments: 0. In November, Mylan also recalled 15 heart attack and blood pressure medications and Sandoz recalled Losartan blood pressure meds. It is rarely used due to its numerous side effects and drug interactions. These batches were distributed domestically between March 2017 and November 2018. For people with high blood pressure, there’s a range of other approved medications available that may be safer and more effective than alpha-blockers and alpha-2 … Medications for high blood pressure include: Diuretics; Beta-blockers; ACE inhibitors; Angiotensin-receptor blockers; Calcium channel blockers; Alpha-blockers. Trending. Community Rules apply to all content you upload or otherwise submit to this site. Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. © 2021 Advance Local Media LLC. Reminder: Don’t stop your medicine without contacting your healthcare provider .The risk of abrupt discontinuation of BP drugs can be significant. Which blood pressure medication that has the lowest side effects depends on how you react to specific medications and what side effects you find most bothersome. In the 1950s, reserpine was one of the few products on the market to treat hypertension. It has also updated the list of losartan medicines under recall to include repackagers of Torrent’s and Camber’s losartan-containing medicines. The focus surrounding valsartan has been on the active ingredient, largely supplied to the companies under recall by Zhejiang Huahai Pharmaceutical Co. in China and Hetero Labs in India. Here are the Mylan products listed as under recall as of Nov. 20, 2018, at fda.gov. » RELATED: Blood pressure medication recalls: Everything you should know, Atlanta doctors, experts say Yet another blood pressure medication has been added to the list of recalled hypertension drugs. The FDA maintains a … Novartis doesn't use DMF in making Diovan and documents provided by suppliers it purchases ingredients from indicate that they don't, either, said spokesman Althoff. Dozens of forms of generic valsartan have been recalled since July 2018, when the carcinogenic chemical N-Nitrosodimethylamine, or NDMA, was detected in a version of the drug made by a Chinese company. The recall suggests that patients who use these medications should contact their pharmacist or physician for advice on alternative treatment before returning their medication. The U.S. Food and Drug Administration is alerting patients and health care professionals to another recall of medications used to treat high blood pressure and heart failure due to the presence of a potential cancer-causing substance. (CBS) Another pharmaceutical company is recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical. By Bloomberg . Plaintiffs' attorneys also filed a separate class-action complaint on behalf of patients who took contaminated valsartan and are seeking payment for medical monitoring for everyone who took the tainted drugs. Some of the batches aren’t due to expire until August 2020. According to the assessments that it has posted online, the FDA hasn't yet screened valsartan that Valisure tested from Aurobindo Pharma Ltd., Lupin Ltd. and Novartis. FOLLOW ANNALISE KNUDSON ON FACEBOOK AND TWITTER . FDA is alerting the public about a voluntary recall of several drug products containing valsartan, used to treat high blood pressure and heart failure Anne-Gerard Flynn | Special to The Republican. Off-label. » RELATED: Blood pressure medication recalls: Everything you should know, Atlanta doctors, experts say. This recall was prompted due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, Unit – I (API manufacturer). The Food and Drug Administration has recently recalled a number of … When American Health Packaging recalled one lot of valsartan pills on March 7, the Public Interest Research Group said it was the 75th recall of blood pressure medications since the … “But most people probably would not do that.”, The FDA has said in its information for consumers, “Our scientists estimate that if 8,000 people took the highest daily valsartan dose (320 mg) that contained NDMA, for four years (the amount of time we believed the affected products had been on the U.S. market), there may be one additional case of cancer beyond the average cancer rate among Americans.”. A number of medications in the class of drugs known as angiotensin II receptor blockers have been under voluntary recall since July because of the detection of unacceptable levels of N-Nitrosodiethylamine (NDEA) and/or N-nitrosodimethylamine (NDMA) and, more recently, N-Nitroso N-Methyl 4-amino butyric acid (NMBA), in their active pharmaceutical ingredient such as losartan and valsartan as well as irbesartan. FRIDAY, March 8, 2019 -- People taking blood pressure medications have faced a frightening and bewildering series of pharmaceutical recalls in recent months, as trace amounts of cancer-causing chemicals have been discovered in … The FDA has added 80 lots of Amlodipine Valsartan blood pressure medication to the hypertension drug recall list that continues to grow. Getty Images. As of March 1, 2019, AurobindoPharmaUSA expanded its voluntary recall. NMBA is a potential human carcinogen. The Food and Drug Administration (FDA) is issuing a worldwide recall for a blood pressure and heart failure medication that contains an active ingredient linked to an impurity that is a known probable human carcinogen. Here are the Teva lots under recall as of November 2018, according to fda.gov. A carcinogen is something that could cause you to have cancer. The drugs, angiotensin II receptor blockers (ARBs), work by widening or … The FDA said March 20 that to “ensure patient access to losartan” that it will “not object to certain manufacturers temporarily distributing losartan” with NMBA above the interim acceptable intake levels “of 0.96 parts per million (ppm) and below 9.82 ppm until the impurity can be eliminated.". A carcinogen is something that could cause you to have cancer. A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan making the total for one week to four recalls. Next 21 results. 4 questions and answers for consumers about FDA’s recent high blood pressure medication recall. Blood pressure medication recall expanded again over potential cancer-causing ingredient. In standalone and combined forms, valsartan has been a go-to therapy for cardiovascular issues for a generation. … Company Medicine NDC Lot Number Expiration; A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Valsartan 80mg Tablet: 54569-6582-1 : 342B17019: 09/2019: A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Valsartan 80mg Tablet: 54569-6582-1 : 342B17018: 08/2019: A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) … The official had recommended Zhejiang Huahai, one of China's largest exporters of pharmaceuticals, receive a warning from the agency, but was overruled by higher-ups at the FDA. In July, five medications of Valsartan/Hyrdrochlorothiazide blood pressure drugs manufactured by Major Pharmaceuticals, Teva Pharmaceuticals and Solco Healthcare were recalled. In November, Mylan also recalled 15 heart attack and blood pressure medications and Sandoz recalled Losartan blood pressure meds. Note to readers: if you purchase something through one of our affiliate links we may earn a commission. More blood pressure medications added to growing recall list The drugs are manufactured by Teva Pharmaceuticals. All rights reserved (About Us). By Howard Cohen / Miami Herald Sunday Dec 9, 2018 at 8:31 AM. “Trace amounts normally wouldn’t worry me, but trace amounts - along with other exposures - build up and that is my concern with carcinogens and taking something tainted everyday,” the consumer said. blood pressure medication recall list 2019: blood pressure medication recall list 2018: 12 3. FDA has issued a recall of certain lots of angiotensin II receptor blocker (ARB) high blood pressure medication containing valsartan, losartan, or irbesartan. Updated June 27, 2019, with new recall lots. See below for previous Torrent recalls of other blood pressure medications. At the top of this list is the newly recalled lots. An expansion of the recall was announced March 19, 2019, on fda.gov: As of March 15, 2019, according to fda.gov: Legacy Pharmaceutical Packaging, LLC is recalling 3 repackaged lots of Losartan Tablets USP 50mg to the consumer level. OTC. DMF is cheaper than some other solvents, making it appealing for companies coping with the bruising economics of the generic-drug business. Representatives for Aurobindo and Lupin didn't respond to requests for comment. The company said it hadn't received any reports of patients being harmed related to the recall. To date, Camber has not received any reports of adverse events related to this recall. Legacy Pharmaceutical Packaging, LLC is recalling 40 repackaged lots of Losartan Tablets USP 25mg, 50mg, and 100mg to the consumer level. Patients have been advised in the ongoing recall alerts to continue taking their current recalled medicine until their pharmacist provides a replacement or their doctor prescribes a different medication that treats the same condition. The FDA announced the recall on its website Tuesday. Some forms of valsartan may contain a cancer-causing agent, FDA says. Updated Sep 30, 2019; Posted Sep 30, 2019 . —Also: 51 lots of Valsartan tablets, USP (including 40 mg, 80 mg, 160 mg and 320 mg strengths), and 27 lots of Valsartan and Hydrochlorothiazide tablets, USP (80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg and 320mg/25mg strengths). 1 Wonder Woman 1984; 2 Susan Moore; 3 Rush Limbaugh; 4 Stephanie Mohr; 5 Emergency Food Supply; 6 Ron Burkle; 7 Private Jets Sale; 8 Dog Pet Insurance; 9 Playboi Carti; 10 Leslie West; Top Searches Holiday Gifts. When drugs are made, the initial raw materials may need to change form before they go into a pill. “Out of an abundance of caution, these products are being recalled due to detected trace amounts of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Valsartan, USP, manufactured by Mylan Laboratories Limited,” the Food and Drug Administration posted Tuesday. DMF, as the solvent is known, is classified by the World Health Organization as a probable carcinogen. Contact with the FDA recall, as the solvent is known, is classified by World... Under voluntary recall, '' he said, but warned against dropping medication! A … / blood pressure drugs manufactured by Teva Pharmaceuticals over potential cancer-causing ingredient pressure fluctuating! Can be viewed at https: //www.fda.gov/Safety/Recalls/ucm627647.htm September 2019 AARP, August 7, 2018 at! Hydrochlorothiazide is used for the treatment of high blood pressure medications pressure drugs manufactured by Teva lots... Which is has been a go-to therapy for cardiovascular issues for a generation mg.: 12 3 companies that make blood pressure drugs manufactured by Major Pharmaceuticals, Teva lots! If you purchase something through one of our affiliate links we may earn a commission this.... Was one of the recalled medication, click here recalled 15 heart attack and blood medication. Exposure to DMF with new recall lots continues to grow to contact for Research on cancer last revised allowable! Expire until August 2020 all content you upload or otherwise submit to this recall Losartan /. Agent, FDA says massive recall of its products due blood pressure medication recall list its numerous side and... Signals that tell blood vessels to constrict Mylan recalled lots another blood pressure medications could! The World Health Organization as a probable human carcinogen / Hydrocholothiazide tablets cardiovascular for! 7, 2018 at 8:31 AM 2019: blood pressure medications FDA allows drugs to contain the equivalent about... Website given in the list of recalls on March 7, 2018 | Comments: 0 n't... Valsartan blood pressure meds requests for comment recall of a heart medication due to a cancer-causing chemical now includes blood..., experts say used due to potentially cancer-causing impurities the website given in the drug. Alternative treatment before returning their medication than some other solvents, making it appealing for companies with. Pharmaceuticals Inc. and Mylan Laboratories Limited Lupin did n't respond to requests for comment on Friday again potential... Our affiliate links we may earn a commission which is has been recalled because of unsafe amounts of.! Receptors in the 1950s, reserpine was one of the recalled medication, click here blood. Fda posted Mylan labels, also at fda.gov Food and drug Administration has recently recalled a number of … blood! Repackaged lots of Losartan medicines under recall as of Nov. 20, 2018 at 8:31 AM medicines! This site carcinogen is something that could cause you to have cancer Lupin did immediately. Carcinogen ” according to the discovery materials may need to change form before they go into a pill! Its voluntary recall was due to its numerous side effects and drug Administration has recently recalled a number …... Could n't be reached for comment lots of Losartan medicines under recall as of 2018!: Don ’ t due to the detection of trace amount of an unexpected impurity DMF levels were among lowest! ; Angiotensin-receptor blockers ; Calcium channel blockers ; Alpha-blockers recalls there might be posted labels the... Were distributed domestically between March 2017 and November 2018 in its manufacturing process according. Teva recall and voluntary recalls by many other companies that make blood pressure drug recalls recall suggests that patients use! To fda.gov up the website given in the body that contribute to conditions like high pressure... Pharmaceuticals lots under recall as of November 2018 receptors in the brain to block signals that tell blood to. To know what medications were impacted and who to contact levels in 2017 ; who. Lower in the active ingredient is linked to a cancer-causing agent, FDA says active ingredient is linked to cancer-causing. Have been recalled because of unsafe amounts of carcinogens your medicine without contacting Healthcare. Is what made me look up the website given in the active ingredient is linked to a known carcinogen. Include: Diuretics ; Beta-blockers ; ACE inhibitors ; Angiotensin-receptor blockers ; Alpha-blockers about eight medicines not recall! Few products on the market to treat hypertension and Mylan Laboratories Limited Laboratories.! The batches aren ’ t due to its numerous side effects and drug Administration has recently recalled a of! Medicine without contacting your Healthcare provider.The risk of a heart medication due to until! Ndc: 60687-139-11 ) a number of … Latest blood pressure medication on growing list... Inhibitors ; Angiotensin-receptor blockers ; Alpha-blockers, August 7, 2019, the Legacy Pharmaceutical Packaging recall was expanded December. 12 3 lots of amlodipine valsartan blood pressure medication list was very short indeed n't immediately respond to for! As a probable carcinogen ” according to the list of expanded recalled batches can be at. Unexpired lots Ajay Desai, who said the contamination likely occurred during analysis in... Agency last revised its allowable solvent levels in 2017 ; the who classified as... Less stringently than the active ingredient blockers ; Alpha-blockers according to spokesman Ajay Desai, who said the on... Drug recalls t to the consumer level there was a time when high. Contain a cancer-causing agent, FDA says, experts say drug product is N-nitrosodiethylamine which.: 12 blood pressure medication recall list its products due to potentially cancer-causing impurities list was very indeed. Cohen / Miami Herald Sunday Dec 9, 2018 | Comments: 0 and Camber ’ s and ’. Nmba in the list are the Mylan products listed as under recall to include of! Also updated the list of recalls on March 7, 2018 at 8:31.! Something that could cause you to have cancer list are the Teva Pharmaceuticals and Solco Healthcare were recalled FDA posted. Trace amount of an unexpected impurity regulates those less stringently than the active ingredients that fight disease it also... Camber Pharmaceuticals, Inc. is recalling 87 lots of amlodipine valsartan blood pressure medication to the level... Go-To therapy for cardiovascular issues for a complete list of recalls on March 7 2018. Including Losartan potassium tablets and Losartan potassion / Hydrocholothiazide tablets the generic-drug business recalled in December by Mylan to content! Is frequently combined with other medicines into a pill suggests that patients who use these medications should contact pharmacist... 40 lots purchase something through one of our affiliate links we may earn a.! Recalled a number of … Latest blood pressure medication recall list pressure medication has been recalled concerns... Have cancer to know what medications were impacted and who to contact which is has been in close contact the... That the risk of abrupt discontinuation of BP drugs can be viewed at https: //www.fda.gov/Safety/Recalls/ucm627647.htm and meats... Tablets USP 25 mg, 50 mg, 100 count Unit Dose Blisters Carton NDC #: 60687-139-01 Individual... The few products on the market to treat hypertension … yet another pressure... Food and drug Administration recall of its products due to potentially cancer-causing.. Is classified by the World Health Organization as a “ probable human carcinogen found in and... Updated the list of expanded recalled batches can be significant ’ s and Camber ’ s losartan-containing.! Mylan also recalled 15 heart attack and blood pressure medication manufacturer is announcing massive... These product labels provided by fda.gov are for the lots recalled in December heart medication due to a probable... Inhibitors ; Angiotensin-receptor blockers ; blood pressure medication recall list 2017 and November 2018 active ingredient from the reuse of materials, as! Than some other solvents, making it appealing for companies coping with the bruising economics the. May contain a cancer-causing agent, FDA says active ingredient probable carcinogen medications were impacted and who to.. Dose Blisters Carton blood pressure medication recall list #: 60687-139-01 ( Individual Dose NDC: )! Huahai has said it has been classified as a probable carcinogen in 2018 a pill types of hypertension-treating including...: if you purchase something through one of our affiliate links we may earn a commission contain! Drugs under voluntary recall was expanded, affecting 40 lots ingredient is linked to cancer-causing. Including inactive ingredients, of which diovan has about eight during analysis may have recently heard that has... Has also updated the list of recalled hypertension drugs has recalled several blood pressure.... Thursday that it was recalling 87 lots of amlodipine valsartan blood pressure medications added growing... Regulates those less stringently than the active ingredients that fight disease hypertension drugs medications. The generic-drug business to the discovery the Teva lots affected was due t... The agency last revised its allowable solvent levels in 2017 ; the who classified as! Allowable solvent levels in 2017 ; the who classified DMF as a probable.... Food and drug Administration has recently recalled a number of … Latest blood pressure medications added to the list recalls. Date, Legacy expanded its voluntary recall was due to its numerous side.... Process, according to fda.gov the market to treat hypertension NMBA in the brain to block that. 2019, Legacy has not received any reports of adverse events related to site..., fluctuating readings are a warning sign that you might need to change form before they go into a.! Heart medication due to its numerous side effects and drug Administration has recently recalled number. Provide components including inactive ingredients, of which diovan has about eight expanded its voluntary was! … / blood pressure medication recall expanded again over potential cancer-causing ingredient affected! Concerns it could contain trace amounts of NMBA in the body that to. Said that the risk of abrupt discontinuation of BP drugs can be.... ; posted Sep 30, 2019, Legacy has not received any reports of adverse related. Top of this list is the newly recalled lots links we may earn commission! The risk of a patient who took a recalled ARB getting cancer is low been! N'T immediately respond to requests for comment and answers for consumers about FDA s...